Factors Influencing Overall Survival for Patients with Fibrolamellar Hepatocellular Carcinoma: Analysis of the Surveillance, Epidemiology, and End Results Database

Factors Influencing Overall Survival for Patients with Fibrolamellar Hepatocellular Carcinoma: Analysis of the Surveillance, Epidemiology, and End Results Database

Georgios Polychronidis,1 Jincheng Feng,2 Anastasia Murtha-Lemekhova,1 Ulrike Heger,1 Arianeb Mehrabi,1 Katrin Hoffmann1 1Department of General, Visceral and Transplant Surgery, Heidelberg University Clinic, Heidelberg, Germany; 2Department of Hepatobiliary Surgery, Union Hospital, Tongji Medical Col...

Full description

Bibliographic Details
Main Authors:	Polychronidis G, Feng J, Murtha-Lemekhova A, Heger U, Mehrabi A, Hoffmann K
Format:	Article
Language:	English
Published:	Dove Medical Press 2022-01-01
Series:	International Journal of General Medicine
Subjects:	fibrolamellar hepatocellular carcinoma seer
Online Access:	https://www.dovepress.com/factors-influencing-overall-survival-for-patients-with-fibrolamellar-h-peer-reviewed-fulltext-article-IJGM

Similar Items

Radiotherapy for metastatic fibrolamellar hepatocellular carcinoma
by: Justin G. Peacock, et al.
Published: (2013-07-01)

Metastatic Fibrolamellar Hepatocellular Carcinoma to the Pancreas
by: Nicolas A. Villa, et al.
Published: (2015-07-01)

Mixed fibrolamellar hepatocellular carcinoma
by: Faten Limaiem, et al.
Published: (2021-06-01)

Fibrolamellar Carcinoma in a young patient
by: Javier Lizardi Cervera
Published: (2002-10-01)

Clinical and pathological evaluation of fibrolamellar hepatocellular carcinoma: a single center study of 21 cases
by: Aline Lopes Chagas, et al.
Published: (2015-03-01)

Repeated metastasectomy in an adolescent with fibrolamellar hepatocellular carcinoma: A case report
by: Shaheed Merani, et al.
Published: (2016-05-01)

Fibrolamellar hepatocellular carcinoma treated with atezolizumab and bevacizumab: two case reports
by: Ali AL Zahrani, et al.
Published: (2021-03-01)

Fibrolamellar Hepatocellular Carcinoma: Report of a Rare Case with Rapid Progression and Unusual Metastatic Sites
by: Adeleh Rezagholizadeh Shirvan, et al.
Published: (2021-04-01)

Fibrolamellar hepatocellular carcinoma that was successfully treated with surgical resection: a case report
by: Seong Kyun Na
Published: (2022-09-01)

Fibrolamellar hepatocellular carcinoma: current clinical perspectives
by: Lafaro KJ, et al.
Published: (2015-10-01)

Prolonged Complete Response after GEMOX Chemotherapy in a Patient with Advanced Fibrolamellar Hepatocellular Carcinoma
by: Pauline Gras, et al.
Published: (2012-04-01)

Multicentric Fibrolamellar Hepatocellular Carcinoma: A Rare Case Report
by: Mayank Goyal, et al.
Published: (2023-01-01)

Fibrolamellar Carcinoma with DNAJB1-PRKACA Fusion in a 16-Year-Old: Case Report and Review of Literature
by: Varsha Prakash, et al.
Published: (2022-07-01)

Utility of cytokeratin7 immunocytochemistry in the cytopathological diagnosis of fibrolamellar hepatocellular carcinoma
by: Rashi Garg, et al.
Published: (2018-01-01)

Extrahepatic transarterial radioembolization to treat fibrolamellar hepatocellular carcinoma: A case report
by: Damir Ljuboja, MD, MBA, et al.
Published: (2020-12-01)

Bilateral Diffuse Nodular Pulmonary Ossification Mimicking Metastatic Disease in a Patient with Fibrolamellar Hepatocellular Carcinoma
by: Pattamon Sutthatarn, et al.
Published: (2021-03-01)

Clinical Outcomes in Fibrolamellar Hepatocellular Carcinoma Treated with Immune Checkpoint Inhibitors
by: Krista Y. Chen, et al.
Published: (2022-10-01)

An unusual cause of gastric extraluminal compression: fibrolamellar hepatocellular carcinoma
by: Dilettoso Salvatore, et al.
Published: (2013-04-01)

Fibrolamellar Carcinoma: A Multimodal Approach
by: João Vasco Barreira, et al.
Published: (2020-04-01)

Fibrolamellar hepatocellular carcinoma: a case report and gene analysis
by: Akira Watanabe, et al.
Published: (2023-09-01)

Indolent T-lymphoblastic proliferation with fibrolamellar hepatocellular carcinoma developed after colorectal adenocarcinoma: a case report
by: Wen Han, et al.
Published: (2023-05-01)

Current Advances in the Treatment of Fibrolamellar Carcinoma of Liver
by: Gummadi J, et al.
Published: (2023-05-01)

Deleted in Liver Cancer 2 (DLC2) protein expression in hepatocellular carcinoma
by: Dominika Wolosz, et al.
Published: (2019-02-01)

Road map for fibrolamellar carcinoma: progress and goals of a diversified approach
by: Kastenhuber ER, et al.
Published: (2019-01-01)

Treatment Outcomes in Patients with Advanced Fibrolamellar Hepatocellular Carcinoma Under Systemic Treatment: Analysis of Clinical Characteristics, Management, and Radiomics
by: Da Fonseca LG, et al.
Published: (2023-11-01)

Prognostic value of the proportion of the sclerosing component in fibrolamellar liver carcinoma
by: E. Yu. Antonova, et al.
Published: (2021-12-01)

Fibrolamellar liver cancer: the modern concept
by: E. Yu. Antonova, et al.
Published: (2020-12-01)

Differential Diagnosis of Hepatic Mass with Central Scar: Focal Nodular Hyperplasia Mimicking Fibrolamellar Hepatocellular Carcinoma
by: Teodoro Rudolphi-Solero, et al.
Published: (2021-12-01)

Evaluation of Protein Kinase cAMP-Activated Catalytic Subunit Alpha as a Therapeutic Target for Fibrolamellar Carcinoma
by: Stefanie S. Schalm, et al.
Published: (2023-01-01)

DnaJ-PKAc fusion induces liver inflammation in a zebrafish model of fibrolamellar carcinoma
by: Sofia de Oliveira, et al.
Published: (2020-04-01)

Crafting a prognostic nomogram for the overall survival rate of cutaneous verrucous carcinoma using the surveillance, epidemiology, and end results database
by: Siomui Chong, et al.
Published: (2023-03-01)

Influence of marital status on overall survival in patients with ovarian serous carcinoma: finding from the surveillance epidemiology and end results (SEER) database
by: Pei Luo, et al.
Published: (2019-12-01)

Epidemiological and Clinical Characteristics of Five Rare Pathological Subtypes of Hepatocellular Carcinoma
by: Xiaoyuan Chen, et al.
Published: (2022-04-01)

Nomogram for predicting overall survival in patients with triple-negative apocrine breast cancer: Surveillance, epidemiology, and end results-based analysis
by: Yinggang Xu, et al.
Published: (2022-12-01)

An acquired scaffolding function of the DNAJ-PKAc fusion contributes to oncogenic signaling in fibrolamellar carcinoma
by: Rigney E Turnham, et al.
Published: (2019-05-01)

Hepatoid adenocarcinoma of the lung: An analysis of the Surveillance, Epidemiology, and End Results (SEER) database
by: Lei Lei, et al.
Published: (2021-01-01)

Identification of Long Non-Coding RNA Profiles and Potential Therapeutic Agents for Fibrolamellar Carcinoma Based on RNA-Sequencing Data
by: Janghyun Kim, et al.
Published: (2023-08-01)

Influence of marital status on small intestinal adenocarcinoma survival: an analysis of the Surveillance, Epidemiology, and End Results (SEER) database
by: Chen Z, et al.
Published: (2018-11-01)

Incidence trends and survival prediction of hepatoblastoma in children: a population-based study
by: Jincheng Feng, et al.
Published: (2019-10-01)

Surveillance Epidemiology and End Results (SEER) Analysis Demonstrates Improvement in Overall Survival for Cervical Cancer Patients Treated in the Era of Concurrent Chemoradiotherapy
by: Howard C. Hsu, et al.
Published: (2015-04-01)